aminoglutethimide has been researched along with Diabetes Mellitus, Type 1 in 1 studies
Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, JM | 1 |
1 other study available for aminoglutethimide and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
[Changes in pituitary-adrenal function and their response to aminoglutethimide in diabetics].
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Aminoglutethimide; Child; Diabetes Mellitus, T | 1987 |